Adenocarcinoma Of Esophagus Active Not Recruiting Phase 2 Trials for Cixutumumab (DB12250)

Also known as: Adenocarcinoma of Oesophagus / Oesophageal Adenocarcinoma / Adenocarcinoma, Esophageal / Esophageal Adenocarcinomas / Esophageal Adenocarcinoma / Oesophageal adenocarcinoma NOS

IndicationStatusPhase
DBCOND0067383 (Adenocarcinoma Of Esophagus)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01142388Paclitaxel With or Without Cixutumumab as Second-Line Therapy in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction CancerTreatment